Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide vaginal ring in endometriosis-related lesions
2018-000915-26Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in endometriosis, deep infiltrating endometriosis (DIE), endometrioma and 1 more comparing Quinagolide vaginal ring with Placebo vaginal ring (2 arms). Primary endpoint: Change in summed lesion size. Started Nov 2018; status: completed.
02
Drugs
quinagolide
03
Conditions
endometriosisdeep infiltrating endometriosis (DIE)endometriomaadenomyosis
Beyond the preview
Go deeper on 2018-000915-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000915-26.